Pentixapharm Holding AG annual operating income
2021
2022
2023
2024
2025
Pentixapharm Holding AG Operating Income Growth & History (PTP)
Pentixapharm Holding AG's operating income was −€19.9M for fiscal 2025.
View full Pentixapharm Holding AG company overviewPentixapharm Holding AG annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −€19.9M | −€2.5M | — |
| 2024 | 2024-12-31 | −€17.4M | −€11.2M | — |
| 2023 | 2023-12-31 | −€6.2M | −€4.0M | — |
| 2022 | 2022-12-31 | −€2.2M | −€540,000 | — |
| 2021 | 2021-12-31 | −€1.6M | — | — |
Pentixapharm Holding AG quarterly operating income
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −€3.6M | €954,000 | — |
| Q1 2026 | 2026-03-31 | −€3.0M | €1.1M | — |
| Q4 2025 | 2025-12-31 | −€6.4M | — | — |
| Q3 2025 | 2025-09-30 | −€4.6M | — | — |
| Q2 2025 | 2025-06-30 | −€4.5M | — | — |
| Q1 2025 | 2025-03-31 | −€4.2M | — | — |
Pentixapharm Holding AG operating income trends
Between the periods ended 2021-12-31 and 2025-12-31, Pentixapharm Holding AG's operating income decreased from −€1.6M to −€19.9M, a change of −€18.2M. The latest reported quarter, Q2 2026, shows −€3.6M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
reported operating income
TickerStat standardizes operating income reported in company official filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pentixapharm Holding AG source filings ↗